Several small molecule MALT1 inhibitors, which inhibit the protease activity of MALT1, have shown remarkable anti-tumor effects on ABC DLBCL cells in vitro and in vivo (101, 102). This evidence concerns the gene MALT1 and aneurysmal bone cyst.